US Archives - Page 59 of 119 - European Medical Journal

AI Predicts Tuberculosis Risk in HIV: CROI 2025

A machine learning-based model has demonstrated the ability to predict active tuberculosis (TB) in people with HIV (PWH) using clinical data, offering a promising tool for improving early detection and preventive treatment.

Are We Testing the Right Patients for TB? Data from CROI 2025

New data from a 15-year study presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco reveals significant disparities in latent tuberculosis infection (LTBI) testing practices within the United States.

Streamlined Self-Efficacy Measure Enhances ART Outcomes: CROI 2025

A recent study presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco has unveiled a simplified approach to assessing antiretroviral therapy (ART) adherence among pregnant women living with HIV in Malawi.

New Long-Term Solution for Chronic Hand Eczema

A recent phase 3 open-label extension study has demonstrated that delgocitinib cream is both safe and effective for long-term management of chronic hand eczema (CHE) in adults.

Comparing Immunosuppressants: What Works Best in Systemic Sclerosis?

A recent analysis from the RESOLVE-1 trial has highlighted the potential of mycophenolate mofetil (MMF) in treating diffuse cutaneous systemic sclerosis (dcSSc), particularly in early-stage disease.

Remdesivir and COVID-19: Are Treatment Guidelines Keeping Up?

A new systematic review and meta-analysis of over 1.3 million patients has confirmed that remdesivir significantly improves survival rates for hospitalized COVID-19 patients, yet treatment guidelines may not fully reflect this evolving evidence.

Why Diversity in Clinical Trials Matters More Than Ever

Increasing diversity in research, from basic science to clinical trials, remains essential for advancing equitable healthcare outcomes.

Stroke's Financial Toll on Families: New Insights

Financial challenges faced by family surrogate decision-makers of stroke patients were highlighted in a new study that revealed that nearly half experience moderate to severe concerns about affording stroke-related medical expenses.

Continuous Immunotherapy's Impact on Advanced Lung Cancer

In a pivotal development for the oncology community, a recent retrospective study has demonstrated that continuing immunotherapy beyond disease progression offers significant survival benefits for patients with advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

New Discovery Reshapes Alveolar Formation Understanding

For decades, researchers believed that alveoli, the tiny air sacs responsible for gas exchange, formed by airspace subdivision via ingrowing septa.